Exact Mass: 217.1681942
Exact Mass Matches: 217.1681942
Found 241 metabolites which its exact mass value is equals to given mass value 217.1681942,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Propionylcarnitine
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents An O-acylcarnitine compound having propanoyl as the acyl substituent. D002491 - Central Nervous System Agents > D000700 - Analgesics D020011 - Protective Agents > D002316 - Cardiotonic Agents D000893 - Anti-Inflammatory Agents D002317 - Cardiovascular Agents D018501 - Antirheumatic Agents
beta-Alanyl-L-lysine
This compound belongs to the family of Hybrid Peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta). KEIO_ID A127
Gamma-glutamyl-L-putrescine
Gamma-glutamyl-L-putrescine is involved in the putrescine II degradation pathway. γ-glutamyl-L-putrescine reacts with H2O and O2 to produce γ-glutamyl-γ-aminobutyraldehyde, H2O2, and NH4+. γ-glutamyl-L-putrescine is formed from an ATP-driven reaction between putrescine, L-glutamate. Gamma-glutamyl-L-putrescine is involved in the putrescine II degradation pathway.
Prolintane
Prolintane belongs to the family of Amphetamines and Derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
Ethoxyquin
Ethoxyquin is an antioxidant used in animal feeds and for the preservation of colour in the production of chili powder, paprika and ground chilli. Ethoxyquin is formerly used as an agricultural pesticide/herbicide, now superseded. Also used as a post-harvest dip for apples and pears to prevent scald. Antioxidant used in animal feeds and for the preservation of colour in the production of chili powder, paprika and ground chilli. Formerly used as an agricultural pesticide/herbicide, now superseded and is) also used as a post-harvest dip for apples and pears to prevent scald C26170 - Protective Agent > C275 - Antioxidant
N-Desmethylaminopyrine
C12H15N3O (217.12150599999998)
N-Desmethylaminopyrine is a metabolite of Aminophenazone. N-desmethylaminopyrine belongs to the family of Anilides. These are organic compounds derived from oxoacids RkE(=O)l(OH)m by replacing an OH group by the NHPh group or derivative formed by ring substitution.
Propionylcarnitine
Propionylcarnitine is an acylcarnitine. More specifically, it is an propanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Propionylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine propionylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular propionylcarnitine is elevated in the blood or plasma of individuals with methylmalonic academia/methylmalonyl-CoA mutase deficiency (PMID: 26454439, PMID: 25750861, PMID: 31622506, PMID: 30712249), propionic academia/mitochondrial propionyl-CoA carboxylase deficiency (PMID: 31715057, PMID: 28915261), obesity and Type 2 Diabetes Mellitus (PMID: 30186675), cobalamin C deficiency (PMID: 25367534), chronic heart failure (PMID: 22622056), diastolic heart failure (PMID: 26010610), and systolic heart failure (PMID: 26010610). It is also decreased in the blood or plasma of individuals with familial Mediterranean fever (PMID: 29900937) and type 2 diabetes Mellitus (PMID: 19369366). It is also decreased in the urine of individuals with obesity (PMID: 26910390). Propionylcarnitine is also found to be associated with propionic acidemia, which is an inborn error of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. Propionylcarnitine is present in high abundance in the urine of patients with Methylmalonyl-CoA mutase (MUT) deficiency, (together with Methylmalonic acid). MUT is a mitochondrial enzyme that catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA (OMIM 609058 ) [HMDB] Propionyl-L-carnitine is a carnitine derivative and has a high affinity for muscular carnitine transferase. Propionyl-L-carnitine increases cellular carnitine content, thereby allowing free fatty acid transport into the mitochondria. Propionyl-L-carnitine alleviates the symptoms of PAD through a metabolic pathway, thereby improving exercise performance[1].
Alanyllysine
Alanyllysine is a dipeptide composed of alanine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Lysylalanine
Lysylalanine is a dipeptide composed of lysine and alanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Deoxyhypusine
Deoxyhypusine is an amino acid derivative of the unusual amino acid known as hypusine. It is a substrate of Deoxyhypusine synthase which catalyzes the cleavage of the polyamine spermidine and transfer of its 4-aminobutyl moiety to the ε-amino group of one specific lysine residue of the eIF-5A precursor to form deoxyhypusine and 1,3-diaminopropane. By the addition of a hydroxyl group to the deoxyhypusine residue deoxyhypusine hydroxylase mediates the formation of hypusine. [HMDB] Deoxyhypusine is an amino acid derivative of the unusual amino acid known as hypusine. It is a substrate of deoxyhypusine synthase which catalyzes the cleavage of the polyamine spermidine and transfer of its 4-aminobutyl moiety to the ε-amino group of one specific lysine residue of the eIF-5A precursor to form deoxyhypusine and 1,3-diaminopropane. By the addition of a hydroxyl group to the deoxyhypusine residue, deoxyhypusine hydroxylase mediates the formation of hypusine (Wikipedia).
Spermic acid 1
This compound belongs to the family of Beta Amino Acids and Derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom.
O-Propanoyl-D-carnitine
O-Propanoyl-D-carnitine is an acylcarnitine. More specifically, it is an propanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. O-Propanoyl-D-carnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine O-Propanoyl-D-carnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular O-Propanoyl-D-carnitine is elevated in the blood or plasma of individuals with methylmalonic academia/methylmalonyl-CoA mutase (PMID: 26454439, PMID: 25750861, PMID: 31622506, PMID: 30712249), propionic academia/mitochondrial propionyl-CoA carboxylase deficiency (PMID: 31715057, PMID: 28915261), obesity and Type 2 Diabetes Mellitus (PMID: 30186675), cobalamin C deficiency (PMID: 25367534), chronic heart failure (PMID: 22622056), diastolic heart failure (PMID: 26010610), and systolic heart failure (PMID: 26010610). It is also decreased in the blood or plasma of individuals with familial Mediterranean fever (PMID: 29900937) and type 2 diabetes Mellitus (PMID: 19369366). It is also decreased in the urine of individuals with obesity (PMID: 26910390). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
1,2,3,4,5,6-Hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol
3-Propyl-3a,4,5,9b-tetrahydro-2H-benzo[g][1,3]benzoxazole
N-(2,6-Diethylphenyl)-4,5-dihydro-1H-imidazol-2-amine
4-Methyl-alpha-pyrrolidinopropiophenone
CONFIDENCE standard compound; INTERNAL_ID 1699
Me glycoside,N-Ac-alpha-D-Pyranose-4-Amino-2,4,6-trideoxy-3-O-methyl-xylo-hexose
(Z)-dec-2-en-6,8-diynoic acid isobutylamide|2-Decene-6,8-diynoic acid, 9CI-2-Methylpropamide
1-((5S,8S)-6,7,8,9-tetrahydro-2,5-dimethyl-5H-cyclohepta[b]pyridin-8-yl)ethanone|rupestine D
1-C-(3-buten-1-yl)-1-deoxy-beta-DGJ|1-C-(3-buten-1-yl)-1-deoxy-beta-galactonojirimycin
ethoxyquin
C26170 - Protective Agent > C275 - Antioxidant CONFIDENCE standard compound; INTERNAL_ID 421; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7870; ORIGINAL_PRECURSOR_SCAN_NO 7868 CONFIDENCE standard compound; INTERNAL_ID 421; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7879; ORIGINAL_PRECURSOR_SCAN_NO 7876 CONFIDENCE standard compound; INTERNAL_ID 421; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7923; ORIGINAL_PRECURSOR_SCAN_NO 7921 CONFIDENCE standard compound; INTERNAL_ID 421; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7945; ORIGINAL_PRECURSOR_SCAN_NO 7941 CONFIDENCE standard compound; INTERNAL_ID 421; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7914; ORIGINAL_PRECURSOR_SCAN_NO 7909 CONFIDENCE standard compound; INTERNAL_ID 421; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7935; ORIGINAL_PRECURSOR_SCAN_NO 7932 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3652
Prolintane
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
4-(2-Keto-1-benzimidazolinyl)piperidine
C12H15N3O (217.12150599999998)
(5S,8R)-8-ethyl-5-((E)-pent-2-en-4-yn-1-yl)octahydroindolizine
(E)-6,8-dimethyl-5-(pent-2-en-4-yn-1-yl)octahydroindolizine
(1R,4S)-1-methyl-4-((E)-pent-2-en-4-yn-1-yl)octahydro-2H-quinolizine
Deoxyhypusine
An L-lysine derivative in which the N(6) of the lysine is substituted with a 4-aminobutyl group.
N-Desmethylaminopyrine
C12H15N3O (217.12150599999998)
Ala-lys
A dipeptide obtained by formal condensation of the carboxy group of L-alanine with the alpha-amino group of L-lysine.
Prolintan
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
CAR 3:0
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D020011 - Protective Agents > D002316 - Cardiotonic Agents D000893 - Anti-Inflammatory Agents D002317 - Cardiovascular Agents D018501 - Antirheumatic Agents
Zindotrine
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
1-(4-isocyanatophenyl)-4-methylpiperazine
C12H15N3O (217.12150599999998)
n-cyclohexyl-cyclohexylamine hydrochloride
C12H24ClN (217.15971739999998)
4-(2-METHYL-2-PHENYLHYDRAZINYL)-5,6-DIHYDROPYRIDIN-2(1H)-ONE
C12H15N3O (217.12150599999998)
1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOL-6-AMINE
C12H15N3O (217.12150599999998)
4-(4-Methoxy-2-methylphenyl)-5-methyl-1H-pyrazol-3-amine
C12H15N3O (217.12150599999998)
3-((TERT-BUTOXYCARBONYL)AMINO)-2,2-DIMETHYLPROPANOIC ACID
5-hex-1-ynylpyridine-3-carbohydrazide
C12H15N3O (217.12150599999998)
4H-1,3-Oxazine,5,6-dihydro-4,4,6-trimethyl-2-(phenylmethyl)-
(4-AMINO-PIPERIDIN-1-YL)-(4-FLUORO-PHENYL)-METHANONEHYDROCHLORIDE
1-(1-adamantyl)-1H-pyrazol-4-amine(SALTDATA: FREE)
N,N-DIMETHYL-4-((TRIMETHYLSILYL)ETHYNYL)ANILINE
C13H19NSi (217.12866939999998)
prop-2-enyl N-(2,2-dimethoxyethyl)-N-ethylcarbamate
6-methyl-2-(propylamino)-1H-quinazolin-4-one
C12H15N3O (217.12150599999998)
methyl (3R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate
tert-Butyl 4-(fluoromethyl)piperidine-1-carboxylate
2-(5-(TERT-BUTYL)-2-HYDROXYPHENYL)-2-METHYLPROPANENITRILE
2-Methyl-2-propanyl 3-hydroxy-4-(hydroxymethyl)-1-pyrrolidinecarb oxylate
Benzeneacetonitrile,4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethyl-
2-AMINO-1-CYCLOHEXYL-4,5-DIMETHYL-1H-PYRROLE-3-CARBONITRILE
5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-amine
C12H15N3O (217.12150599999998)
6,6-dimethyl-N-phenyl-3H-1,3,5-triazine-2,4-diamine
5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenamine
4-[[(1,1-dimethylethoxy)carbonyl]amino]Butanoic acid methyl ester
1,2,3,4,7,8,9,10-OCTAHYDROBENZO[C]CINNOLIN-1-ONE OXIME
C12H15N3O (217.12150599999998)
Carbamic acid, [3-amino-2-(aminomethyl)-2-methylpropyl]-, 1,1-dimethylethyl
tert-butyl 2-amino-3-[(2-methylpropan-2-yl)oxy]propanoate
(2R,4S)-tert-Butyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate
Pyrimido[1,2-a]benzimidazole, 7-ethoxy-1,2,3,4-tetrahydro- (9CI)
C12H15N3O (217.12150599999998)
Methyl 3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)butanoate
2-Methyl-2-Propanyl {2-[(2-Aminoethyl)(Methyl)Amino]Ethyl}Carbamate
3-[Ethoxy(diisopropyl)silyl]-1-propanamine
C11H27NOSi (217.18618119999996)
1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOL-5-AMINE
C12H15N3O (217.12150599999998)
4-amino-2-spirocyclohexyl-2h-benzimidazol-1-oxide
C12H15N3O (217.12150599999998)
Glycine, N-[(1,1-dimethylethoxy)carbonyl]-, 1-methylethyl ester (9CI)
Tert-butyl 3-hydroxy-3-(hydroxymethyl)pyrrolidine-1-carboxylate
(3R)-3-Methyl-4-({[(2-Methyl-2-Propanyl)Oxy]Carbonyl}Amino)Butanoic Acid
4-(Hexahydro-5-methylpyrrolo[3,4-c]pyrrol-2(1H)-yl)benzenamine
Methyl 3-((tert-butoxycarbonyl)(methyl)amino)propanoate
N-methyl ,ethyl-Morpholinium tetrafluoroborate
C7H16BF4NO (217.12610039999998)
2-(4-Hydroxy-cyclohexylaMino)-nicotInonitrile
C12H15N3O (217.12150599999998)
1-Benzyl-1,2,3,6-tetrahydropyridine-4-boronic acid
4-(4-METHYL-1-PIPERAZINYL)-1H-PYRROLO[2,3-D]PYRIMIDINE
1H-Spiro[piperidine-4,2-quinazolin]-4(3H)-one
C12H15N3O (217.12150599999998)
1H-Inden-1-one,2-[(dimethylamino)methyl]-5-ethyl-2,3-dihydro-(9CI)
1H-Spiro[piperidine-4,4-quinazolin]-2(3H)-one
C12H15N3O (217.12150599999998)
[2-(methacryloyloxy)ethyl]dimethylammonium acetate
(2R,4R)-TERT-BUTYL 4-HYDROXY-2-(HYDROXYMETHYL)PYRROLIDINE-1-CARBOXYLATE
1-(4-Methoxybenzyl)-3-methyl-1H-pyrazol-5-amine
C12H15N3O (217.12150599999998)
Levocarnitine propionate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D020011 - Protective Agents > D002316 - Cardiotonic Agents D000893 - Anti-Inflammatory Agents D002317 - Cardiovascular Agents D018501 - Antirheumatic Agents
N-(2,6-Diethylphenyl)-4,5-dihydro-1H-imidazol-2-amine
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
2-(3,5-dimethyl-1H-pyrazol-1-yl)-N,6-dimethylpyrimidin-4-amine
(3Z)-3-[(4-methylphenyl)hydrazinylidene]piperidin-2-one
C12H15N3O (217.12150599999998)
2,5-Dimethyl-1-(trimethylsilyl)-1H-indole
C13H19NSi (217.12866939999998)
[amino-[[(4S)-4-amino-4-carboxybutyl]amino]methylidene]-propylazanium
2-Cyclopentyl-5-(prop-2-enylamino)-4-oxazolecarbonitrile
C12H15N3O (217.12150599999998)
(2S)-6-amino-2-(3-aminopropanoylamino)hexanoate;hydron
1-[(2-Methylbutan-2-yl)oxy]-3-[(2-methylpropyl)amino]propan-2-ol
(3Z)-3-[(2-methylphenyl)hydrazinylidene]piperidin-2-one
C12H15N3O (217.12150599999998)
Propionyl-L-carnitine-(N-methyl-d3), analytical standard
O-Propanoyl-L-carnitine
An optically active O-acylcarnitine compound having propanoyl as the acyl substituent and (R)-configuration at the 3-position.
4-(methylamino)antipyrine
C12H15N3O (217.12150599999998)
A member of the class of pyrazoles that is antipyrine substituted at C-4 by a methylamino group. It is a metabolite of aminopyrine and of metamizole.
(1r,4s,7s,9r)-9-methyl-8-azatetracyclo[5.5.3.0¹,⁸.0⁴,⁹]pentadec-5-ene
1-[(5s,8s)-2,5-dimethyl-5h,6h,7h,8h,9h-cyclohepta[b]pyridin-8-yl]ethanone
2,6-decamethylene pyridine
{"Ingredient_id": "HBIN004870","Ingredient_name": "2,6-decamethylene pyridine","Alias": "NA","Ingredient_formula": "C15H23N","Ingredient_Smile": "C1CCCCCC2=CC=CC(=N2)CCCC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4830","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
n-(5-{[(2s)-2-hydroxypropanoyl]oxy}pentyl)ethanimidic acid
n-{5-[(2-hydroxypropanoyl)oxy]pentyl}ethanimidic acid
9-ethyl-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine
{[(2r,4r)-2-carboxy-4,5-dihydroxy-3,4-dihydropyrrol-2-yl]methyl}trimethylazanium
1-{2,5-dimethyl-5h,6h,7h,8h,9h-cyclohepta[b]pyridin-8-yl}ethanone
1-methoxy-3-methyl-6h,7h,8h,9h-5λ⁵-pyridazino[1,2-a]indazol-5-ylium
(2z)-n-(2-methylpropyl)dec-2-en-6,8-diynimidic acid
(7r)-2-ethyl-3-propyl-11-azatricyclo[5.3.1.0⁴,¹¹]undeca-1,3-diene
4-[(1e)-2-[(2s)-1-methylpiperidin-2-yl]ethenyl]phenol
9-methyl-8-azatetracyclo[5.5.3.0¹,⁸.0⁴,⁹]pentadec-5-ene
(1s,9r,10r)-9-ethyl-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-4(12),7-dien-6-imine
2-[(2-hydroxy-3-methylbutanoyl)oxy]-3-methylbutanimidic acid
(2s)-2-amino-4-[(4-aminobutyl)-c-hydroxycarbonimidoyl]butanoic acid
ethyl({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)amine
C12H15N3O (217.12150599999998)